Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Medchemexpress LLC Terazosin-d8 | 1006718-20-2 | 99.2% | 2.5 MG
Supplier: Medchemexpress LLC HYB0371S2.5MG
Terazosin-d8 is a deuterium-labeled quinazoline derivative and a competitive, orally active α1-adrenoceptor antagonist. It functions by relaxing blood vessels and opening the bladder, making it suitable for potential applications in treating benign prostatic hyperplasia (BPH) and high blood pressure. Deuteration influences the pharmacokinetic and metabolic profiles of drugs.
- Competitive and orally active α1-adrenoceptor antagonist
- Relaxes blood vessels and opens the bladder
- Potential for benign prostatic hyperplasia (BPH) treatment
- Potential for high blood pressure treatment
- Can be used as a tracer or an internal standard
- Suitable for quantitative analysis by NMR, GC-MS, or LC-MS
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?